Ampicillin Sodium
Ampicillin Sodium
Sourced from the FDA Orange Book
Key dates
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Pharmaceutical detail
Active ingredient
AMPICILLIN SODIUM
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 061395
Product number
004
Marketing status
Prescription
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Other strengths in ANDA 061395
Active-ingredient family
Generic (ANDA) of Ampicillin Sodium
- —Penbritin-sBrand (NDA)
NDA 050072 · Wyeth Ayerst
- —Polycillin-nBrand (NDA)
NDA 050309 · Bristol
- 2015Ampicillin SodiumGeneric (ANDA)
ANDA 090583 · Sagent Pharms Inc
- 2015Ampicillin SodiumGeneric (ANDA)
ANDA 090581 · Sagent Pharms Inc
- 2015Ampicillin SodiumGeneric (ANDA)
ANDA 202864 · Hospira
- 2015Ampicillin SodiumGeneric (ANDA)
ANDA 202865 · Hospira
- 2014Ampicillin SodiumGeneric (ANDA)
ANDA 201025 · Onesource Specialty
- 2014Ampicillin SodiumGeneric (ANDA)
ANDA 202198 · Onesource Specialty
- 2013Ampicillin SodiumGeneric (ANDA)
ANDA 201404 · Istituto Bio Ita Spa
- 2013Ampicillin SodiumGeneric (ANDA)
ANDA 090884 · Acs Dobfar Spa
- 2013Ampicillin SodiumGeneric (ANDA)
ANDA 090889 · Acs Dobfar Spa
- 2010Ampicillin SodiumGeneric (ANDA)
ANDA 065499 · Eugia Pharma Speclts
Listed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ampicillin Sodium — frequently asked questions
Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.
Built directly from the FDA Orange Book data file. This product page links back to the Ampicillin Sodium active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

